Baxter International, which is streamlining operations to boost growth and profits, has completed the divestiture of its biopharma solutions business during the third quarter and reorganized its remaining businesses into four new segments.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,